{
  "id": 17903555,
  "title": "Omni makes a round to double its drug insurance",
  "url": "https://urgent.news/2026/11/03/omni-faz-rodada-para-dobrar-seu-seguro-de-medicamentos",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-03T03:27:00.000Z",
  "source": {
    "name": "Brazil Journal",
    "slug": "brazil-journal",
    "url": "https://braziljournal.com/omni-faz-rodada-para-dobrar-seu-seguro-de-medicamentos"
  },
  "original_language": "pt",
  "account": "Omni, a Brazilian startup, has closed a funding round to support an aggressive expansion plan, aiming to double its user base by the end of next year and reach R$ 50 million in revenue. The funding round was led by ACNext, a venture capital firm founded by former Accenture executives, and included participation from existing investors GreenRock and Enseada. Omni offers a medication insurance service used by companies such as Azul, Light, MetLife, and Spoleto, and has raised a total of R$ 30 million in three funding rounds since its founding in 2024. The startup aims to reach breakeven by the end of 2027 and has projected revenue of R$ 50 million for that year.",
  "summary": "Omni – which created a drug insurance product that is already used by Azul, Light, MetLife and Spoleto – has just closed a round that will finance an aggressive expansion plan: doubling its base of insured lives by the end of next year, reaching revenue of R$ 50 million. The investment was led by ACNext, a venture capital manager founded by former Accenture executives; and had the participation…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}